Life Sciences Products & Reviews

The XcytoMatic® 40 (XM40™) is a high-throughput cell density and viability analyzer that can run 24 samples in under 14 minutes. The variation between cell counts for these samples is under 3%. If scale-out and scale-up is a concern, you can trust each XM40™ instrument in your production to deliver the same quality results.

Disruptive technology for the characterization of small molecules and fragments. With enhanced sensitivity, expanded thermal options, and advanced microfluidics, the Carterra Ultra™ platform is our most sensitive instrument for interrogating multiple proteins and off-target binding in parallel.

Disruptive Technology for Screening and Characterization. Enhanced sensitivity and fast data collection rate build upon unmatched capabilities in throughput and enable assays such as TPDs/PROTAC®s, kinase, cytokines, DELs, and protein:protein inhibitors.

Recombinant or purified CA19-9 antigen, a sialylated Lewis blood group antigen, which is a widely used serum biomarker for pancreatic and gastrointestinal cancers.

High-purity proteins produced through genetic engineering in heterologous expression systems, ensuring consistency, scalability, and reduced lot-to-lot variability for research and development.

Recombinant Human Programmed Death-Ligand 1 (PD-L1/CD274/B7-H1), the primary ligand for PD-1, expressed on tumor and immune cells to suppress anti-tumor immunity.

Recombinant Human Bone Morphogenetic Protein 7 (BMP-7), a TGF-β superfamily member that induces bone and cartilage formation and plays roles in renal development and repair.

An extensive collection of recombinant Cluster of Differentiation (CD) proteins, which are key cell surface markers for immunophenotyping, immune function studies, and therapeutic targeting.

A comprehensive portfolio of high-quality resins, columns, buffers, and accessories essential for the purification and analysis of biomolecules across discovery and process development scales.

Manufactured under strict Good Manufacturing Practice guidelines, these proteins are designed for use in preclinical, clinical, and therapeutic applications where quality and regulatory compliance are paramount.

Custom modification of protein sequences and structures to enhance properties such as stability, activity, solubility, and specificity for therapeutic and industrial applications.

Recombinant Human Bone Morphogenetic Protein 2 (BMP-2), a key regulatory protein that induces bone and cartilage formation, used extensively in orthopedics and stem cell differentiation.

Development of custom mammalian stable cell lines that consistently express your target protein of interest, ideal for long-term research, assay development, and production.

Recombinant Human Apolipoprotein E (ApoE), a key protein in lipid metabolism that plays a central role in cardiovascular health and Alzheimer's disease pathogenesis.

A comprehensive collection of active, recombinant protein kinases, crucial for screening and profiling small molecule inhibitors and studying cellular signaling pathways in disease.

Proteins purified from their natural, endogenous sources, preserving post-translational modifications and complex native structures for biologically relevant research applications.

Professional services for site-specific or random labeling of proteins with a variety of tags, including fluorescent dyes, biotin, enzymes, and isotopes, for detection and tracking.

A specialized selection of high-purity, carrier-free cytokines and growth factors optimized for the robust and reproducible growth and differentiation of 3D organoid models.

High-quality recombinant TGF-β superfamily proteins, including TGF-βs, BMPs, and GDFs, for studying cell growth, differentiation, embryogenesis, and tissue repair.

A diverse range of recombinant proteins and antigens associated with specific physiological or pathological states, supporting discovery, assay development, and diagnostic validation.

A service to identify the RNA targets of RNA-binding proteins (RBPs) on a genome-wide scale, providing insights into post-transcriptional regulatory networks.

Recombinant Human B-cell lymphoma 2 (BCL-2) protein, a key regulator of apoptosis (programmed cell death) and a well-established oncoprotein in many cancers.

Recombinant Human B-cell Antigen Receptor Complex-associated protein alpha chain (CD79A), a essential component of the B-cell receptor (BCR) and a marker for B-cell lineage.

Specialized services for the challenging production of functional, stabilized membrane proteins, including GPCRs, ion channels, and transporters, for structural and drug discovery.

End-to-end custom services for the cloning, expression, and purification of soluble recombinant proteins in various host systems, from gene synthesis to purified protein delivery.